Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up. [electronic resource]
Producer: 20141215Description: e126-31 p. digitalISSN:- 1532-0987
- Adolescent
- Anti-Retroviral Agents -- administration & dosage
- Antibodies -- blood
- Antiretroviral Therapy, Highly Active -- methods
- B-Lymphocytes -- immunology
- Cell Survival
- Child
- Enzyme-Linked Immunosorbent Assay
- Enzyme-Linked Immunospot Assay
- Female
- Flow Cytometry
- Follow-Up Studies
- HIV Infections -- drug therapy
- Humans
- Male
- Time Factors
- Vaccines -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.